Prostate Cancer - Results from #200

Mark Cuban Pharmacy Could Save Billions on Prostate Cancer, Bladder Drugs February 10, 2023

Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. February 10, 2023

Impact of previous depression on the risk of suicide among prostate cancer patients. February 10, 2023

Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance. February 10, 2023

Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study. February 10, 2023

Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer. February 10, 2023

DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. February 9, 2023

Impact of 3D printed models on quantitative surgical outcomes for patients undergoing robotic-assisted radical prostatectomy: a cohort study. February 9, 2023

Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer. February 9, 2023

European Association of Urology Biochemical Recurrence Risk Groups after radical prostatectomy: external validation and identification of independent risk factors for progression and death: Grupos De Riesgo De Recidiva Bioquímica Tras Prostatectomía Radic February 9, 2023

Role, race, and place: Prostate cancer disparities in Patients' and Partners' health outcomes and psychosocial factors. February 9, 2023

Prostate Cancer Tumor Volume and Genomic Risk. February 8, 2023

The combination of prostate MRI PI-RADS scoring system and a genomic classifier is associated with pelvic lymph node metastasis at the time of radical prostatectomy. February 8, 2023

Prospective Long-term Health-related Quality of Life Outcomes After Surgery, Radiotherapy, or Active Surveillance for Localized Prostate Cancer. February 8, 2023

Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic U February 8, 2023

Eligibility for 177Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer February 7, 2023

Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy. February 7, 2023

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation. February 7, 2023

Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer. February 7, 2023

Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX). February 7, 2023

Page 11 of 1288